Gardasil9 Vaccine for Human Papillomavirus

Recruiting in Palo Alto (17 mi)

Overseen byNatalie Pierre-Joseph, MD

Age: < 18

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase < 1

Waitlist Available

Sponsor: Boston Medical Center

No Placebo Group

Trial Summary

What is the purpose of this trial?This trial tests if two shots of an HPV vaccine can help boys and girls aged 4-8 years build strong defenses against nine types of HPV. The goal is to see if young children can develop a good immune response similar to older kids.

Eligibility Criteria

This trial is for children aged 4-8 who get care at Boston Medical Center or its community health centers and have never had an HPV vaccine. It's not for kids with blood clotting issues, severe allergies (especially to yeast), or weakened immune systems.

Inclusion Criteria

Receives care at the Boston Medical Center or one of the affiliated Community Health Centers

My child is between 4 and 8 years old.

I have never received the HPV vaccine.

Exclusion Criteria

History of severe allergic reaction, including known allergy to any vaccine component, especially severe allergic reaction to yeast

I have a weakened immune system or have been on drugs that lower my immunity.

I have a blood clotting disorder or low platelet count.

Participant Groups

The study tests the effectiveness of a two-dose regimen of Gardasil9, an HPV vaccine, given over one year to prevent warts and human papillomavirus in young children.

1Treatment groups

Experimental Treatment

Group I: Single ArmExperimental Treatment1 Intervention

HPV 9-valent human papillomavirus vaccine (Gardasil 9) - 0.5mL intramuscular dose - 2 doses (Month 0, 12)